Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval.
Source link
Tags: 4523.TO, Alvaro Pascual-Leone, Alzheimer's Disease, Art Nagle, BIIB, Biogen, C&E Industry News Filter, Content Types, corporate, Corporate/Industrial News, Dementia, Eisai, Eli Lilly, Factiva Filters, Financial Services, general news, government policy, Government Sponsored Health Insurance, Health, Health/Medical Insurance, healthcare, Healthcare/Life Sciences, industrial news, Insurance, Jason Karlawish, Jay Reinstein, Jeffrey Burns, JP:4523, Julio Rojas, life sciences, LLY, Medical Conditions, medical insurance, medical treatments, Medical Treatments/Procedures, medications, Mental Disorders, Neurodegenerative Disease Drugs, new products, New Products/Services, Non-life Insurance, Paige Nagle, Pharmaceuticals, political, Political/General News, procedures, product, Product/Service Approvals, products, Products/Services, regulation, Regulation/Government Policy, service approvals, services, specialized drugs, Specialized Drugs/Medications, SYND, Teresa Buracchio, WSJ-PRO-WSJ.com, wsjhealth
